Garcia-C alvo M, Peterson EP, Rasper DM, Vaillancourt JP, Z amboni R,
Nicholson DW, Thornberry NA (1999) Purification and catalytic
properties of human caspase family members. C ell Death Differ
6:362–369.
Gervais FG, Xu D, Robertson GS, Vaillancourt JP, Z hu Y, Huang J,
LeBlanc A, Smith D, Rigby M, Shearman MS, C larke EE, Z heng H,
Van Der Ploeg L H, Ruffolo SC, Thornberry NA, Xanthoudakis S,
Z amboni RJ, Roy S, Nicholson DW (1999) Involvement of caspases in
proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and
amyloidogenic A beta peptide formation. C ell 97:395– 406.
Goldberg YP, Nicholson DW, Rasper DM, Kalchman M A, Koide HB,
Graham RK , Bromm M, Kazemi-Esfarjani P, Thornberry NA, Vaillancourt JP, Hayden MR (1996) C leavage of huntingtin by apopain, a
proapoptotic cysteine protease, is modulated by the polyglutamine
tract. Nat Genet 13:442– 449.
Gutekunst CA, Li SH, Yi H, Mulroy JS, Kuemmerle S, Jones R, Rye D,
Ferrante RJ, Hersch SM, Li XJ (1999) Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J Neurosci 19:2522–2534.
Hackam AS, Singaraja R, Wellington CL, Metzler M, McCutcheon K ,
Z hang T, Kalchman M, Hayden MR (1998) The influence of huntingtin protein size on nuclear localization and cellular toxicity. J C ell Biol
141:1097–1105.
Hayden MR (1981) Huntington's chorea. Berlin: Springer.
Hodgson JG, Agopyan N, Gutekunst CA, Leavitt BR, LePiane F, Singaraja R, Smith DJ, Bissada N, McCutcheon K , Nasir J, Jamot L, Li XJ,
Stevens M E, Rosemond E, Roder JC, Phillips AG, Rubin EM, Hersch
SM, Hayden MR (1999) A YAC mouse model for Huntington's disease with f ull-length mutant huntingtin, cytoplasmic toxicity, and se- lective striatal neurodegeneration. Neuron 23:181–192.
Huntington's Disease Collaborative Research Group (1993) A novel
gene containing a trinucleotide repeat that is expanded and unstable on
Huntington's disease chromosomes. C ell 72:971–983.
Kalchman M A, Koide HB, McCutcheon K , Graham RK , Nichol K ,
Nishiyama K , Kazemi-Esfarjani P, Lynn FC, Wellington C, Metzler M,
Goldberg YP, Kanazawa I, Gietz RD, Hayden MR (1997) HI P1, a
human homologue of S. cerevisiae Sla2p, interacts with membraneassociated huntingtin in the brain. Nat Genet 16:44 –53.
Kawamura T, Akira T, Watanabe M, Kagitani Y (1997) Prostaglandin
E1 prevents apoptotic cell death in superficial dorsal horn of rat spinal
cord. Neuropharmacology 36:1023–1030.
K im YJ, Yi Y, Sapp E, Wang Y, Cuiffo B, Kegel K B, Qin Z-H, Aronin
N, DiFiglia M (2001) C aspase 3-cleaved N-terminal fragments of wildtype and mutant huntingtin are present in normal and Huntington's
disease brains, associate with membranes, and undergo calpaindependent proteolysis. Proc Natl Acad Sci USA 98:12784 –12789.
Kuida K , Z heng TS, Na S, Kuan C, Yang D, Karasuyama H, Rakic P,
Flavell R A (1996) Decreased apoptosis in the brain and premature
lethality in C PP32-deficient mice. Nature 384:368 –372.
Laforet GA, Sapp E, Chase K , McIntyre C, Boyce FM, C ampbell M,
C adigan BA, Warzecki L, Tagle DA, Reddy PH, C epeda C, C alvert
CR, Jokel ES, K lapstein GJ, Ariano M A, Levine MS, DiFiglia M,
Aronin N (2001) Changes in cortical and striatal neurons predict be- havioral and electrophysiological abnormalities in a transgenic murine
model of Huntington's disease. J Neurosci 21:9112–9123.
Leavitt BR, Guttman JA, Hodgson JG, K imel GH, Singaraja R, Vogl
AW, Hayden MR (2001) Wild-type huntingtin reduces the cellular
toxicity of mutant huntingtin in vivo. Am J Hum Genet 68:313–324.
Levine MS, K lapstein GJ, Koppel A, Gruen E, C epeda C, Vargas M E,
Jokel ES, C arpenter EM, Z anjani H, Hurst RS, Efstratiadis A, Z eitlin
S, Chesselet M F (1999) Enhanced sensitivity to N-methyl-D-aspartate
receptor activation in transgenic and knockin mouse models of Huntington's disease. J Neurosci Res 58:515–532.
Li H, Li SH, Cheng AL, Mangiarini L, Bates GP, Li XJ (1999) Ultrastructural localization and progressive formation of neuropil aggregates
in Huntington's disease transgenic mice. Hum Mol Genet 8:1227–1236.
Li H, Li S-H, Johnston H, Shelbourne PF, Li X-J (2000) Amino-terminal
fragments of mutant huntingtin show selective accumulation in striatal
neurons and synaptic toxicity. Nat Genet 25:385–389.
L uthi-C arter R, Strand A, Peters N L, Solano SM, Hollingsworth Z R,
Menon AS, Frey AS, Spektor BS, Penney EB, Schilling G, Ross CA,
Borchelt DR, Tapscott SJ, Young AB, Cha J-H, Olson JM (2000)
Decreased expression of striatal signaling genes in a mouse model of
Huntington's disease. Hum Mol Genet 9:1259 –1271.
Mangiarini L, Sathasivam K , Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996)
E xon 1 of the H D gene with an expanded CAG repeat is sufficient to
cause a progressive neurological phenotype in transgenic mice. C ell
87:493–506.
Martindale D, Hackam A, Wieczorek A, Ellerby L, Wellington C, Mc- Cutcheon K , Singaraja R, Kazemi-Esfarjani P, Devon R, K im SU,
Bredesen DE, T ufaro F, Hayden MR (1998) Length of huntingtin and
its polyglutamine tract influences localization and frequency of intracellular aggregates. Nat Genet 18:150 –154.
Mende-Mueller L M, Toneff T, Hwang S-R, Chesselet M-F, Hook V YH
